ANO1 and breast cancer: The cell-specific role of TMEM16A has also been demonstrated by Britschgi et al., showing that knockdown of TMEM16A resulted in decreased secretion of EGFR ligands (EGF and TGF-α) in breast cancer cells, but not in HNSCC cells [42].